Venture Life Group PLC Completion of Acquisition (8958A)
24 Gennaio 2020 - 01:37PM
UK Regulatory
TIDMVLG
RNS Number : 8958A
Venture Life Group PLC
24 January 2020
24 January 2020
Venture Life Group plc
("Venture Life" or the "Group")
Completion of Acquisition
Venture Life Group plc (AIM: VLG), a leader in developing,
manufacturing and commercialising products for the international
self-care market, announces that the conditions to achieve
completion of its acquisition of PharmaSource BV as previously
announced on 19(th) December 2019 have now been met and the
Completion has taken place today.
For further information, please contact:
+44(0) 1344
Venture Life Group plc 578004
Jerry Randall, Chief Executive Officer
+44(0)20 7397
Cenkos Securities plc (Nomad and Broker) 8900
Mark Connelly / Stephen Keys / Cameron MacRitchie
(Corporate Finance)
Russell Kerr / Michael Johnson (Sales)
+44(0)20 3405
Alma PR 0208
Hilary Buchanan / Helena Bogle / Jessica Joynson
/ Kieran Breheny
About Venture Life (www.venture-life.com)
Venture Life is an international consumer self-care company
focused on developing, manufacturing and commercialising products
for the global self-care market. With operations in both the UK and
Italy, the Group's product portfolio includes some key products
such as the UltraDEX and Dentyl oral care product ranges, food
supplements for maintaining brain function, medical devices for
women's intimate healthcare and proctology and dermo-cosmetics for
addressing the signs of ageing.
The products, which are typically recommended by pharmacists or
healthcare practitioners, are available primarily through
pharmacies and grocery multiples. In the UK these are supplied
direct by the company, outside of the UK they are supplied by the
Group's international distribution partners.
Through its Development & Manufacturing business in Italy,
Biokosmes, the Group also provides development and manufacturing
services to companies in the medical devices and cosmetic
sectors.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
ACQSEIFELESSEDF
(END) Dow Jones Newswires
January 24, 2020 07:37 ET (12:37 GMT)
Grafico Azioni Venture Life (LSE:VLG)
Storico
Da Feb 2024 a Mar 2024
Grafico Azioni Venture Life (LSE:VLG)
Storico
Da Mar 2023 a Mar 2024